BALDARI COSIMA

Office hours

  • Monday from 11:00 to 13:00
    Note: Contattare preventivamente il docente

Teaching activities

Completion accademic year: 2022/2023

Course year: 1 Second cycle degree (Laurea Magistrale) BIOLOGY A.Y. 2022/2023
Course year: 1 Second cycle degree (Laurea Magistrale) BIOLOGY A.Y. 2022/2023

Completion accademic year: 2021/2022

Course year: 1 ANATOMIA PATOLOGICA A.Y. 2021/2022
Course year: 1 Second cycle degree (Laurea Magistrale) BIOLOGY A.Y. 2021/2022
Course year: 1 Second cycle degree (Laurea Magistrale) BIOLOGY A.Y. 2021/2022

Completion accademic year: 2020/2021

Course year: 1 ANATOMIA PATOLOGICA A.Y. 2020/2021
Course year: 1 Second cycle degree (Laurea Magistrale) BIOLOGY A.Y. 2020/2021
Course year: 1 Second cycle degree (Laurea Magistrale) BIOLOGY A.Y. 2020/2021

Completion accademic year: 2019/2020

Course year: 1 ANATOMIA PATOLOGICA A.Y. 2019/2020
Course year: 1 Second cycle degree (Laurea Magistrale) BIOLOGY A.Y. 2019/2020

Research

Ultime pubblicazioni:

  • Lopresti, L., Capitani, N., Tatangelo, V., Tangredi, C., Boncompagni, G., Frezzato, F., et al. (2024). p66Shc deficiency in CLL cells enhances PD-L1 expression and suppresses immune synapse formation. FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY, 12 [10.3389/fcell.2024.1297116]. - view more
  • Zevolini, F., Onnis, A., Khazen, R., Müller, S., Marotta, G., Valitutti, S., et al. (2024). Polo-like kinase 1 regulates immune synapse assembly and cytotoxic T cell function by driving microtubule dynamics. JOURNAL OF CELL SCIENCE, 137(5) [10.1242/jcs.261476]. - view more
  • Boncompagni, G., Tatangelo, V., Lopresti, L., Ulivieri, C., Capitani, N., Tangredi, C., et al. (2024). Leukemic cell-secreted interleukin-9 suppresses cytotoxic T cell-mediated killing in chronic lymphocytic leukemia. CELL DEATH & DISEASE, 15(2) [10.1038/s41419-024-06528-6]. - view more
  • Montecchi, T., Nannini, G., De Tommaso, D., Cassioli, C., Coppola, F., Ringressi, M.N., et al. (2024). Human colorectal cancer: upregulation of the adaptor protein Rai in TILs leads to cell dysfunction by sustaining GSK-3 activation and PD-1 expression. CANCER IMMUNOLOGY, IMMUNOTHERAPY, 73(1), 2-12 [10.1007/s00262-023-03614-0]. - view more
  • Rossi, S., Tatangelo, V., Dichiara, M., Butini, S., Gemma, S., Brogi, S., et al. (2024). A novel potent class I HDAC inhibitor reverses the STAT4/p66Shc apoptotic defect in B cells from chronic lymphocytic leukemia patients. BIOMÉDECINE & PHARMACOTHÉRAPIE, 174 [10.1016/j.biopha.2024.116537]. - view more